GITFIT
ABMD

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Abiomed Inc ABMD Stock Holding History

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-300
Closed -$73.7K – 85
2022
Q3 		$73.7K Hold
300
– – 0.12% 74
2022
Q2 		$74.3K Hold
300
– – 0.11% 73
2022
Q1 		$99.4K Buy
+300
New +$92.3K 0.11% 72

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $14.7B AUM 42.39% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $537M AUM 18.24% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s ABMD Position: Q4 2022 in Review

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 300 shares — an estimated $73.7K sold.

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in ABMD in Q1 2022 and held it in 3 quarters. The position peaked at $99.4K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) sold 300 Abiomed Inc shares in Q4 2022, an estimated $73.7K.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in Abiomed Inc in Q1 2022 and held it in 3 quarters.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s Abiomed Inc position peaked at $99.4K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s 13F filing for Q4 2022, filed 5 Feb 2025.